Department of Dermatology, Division of Dermatologic Surgery, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas.
Semin Plast Surg. 2008 Nov;22(4):247-56. doi: 10.1055/s-0028-1095884.
Since the inception of Mohs micrographic surgery in the 1930s, this technique has proved its utility in the treatment of cutaneous tumors. This review describes the technique of Mohs micrographic surgery and the various indications for which it is used. We discuss the use of Mohs micrographic surgery for the following cutaneous tumors: basal cell carcinoma, squamous cell carcinoma, melanoma in situ, dermatofibrosarcoma protuberans, Merkel cell carcinoma, microcystic adnexal carcinoma, atypical fibroxanthoma, and sebaceous carcinoma. Mohs micrographic surgery is cost effective in the U.S. health care system because billing for the surgeon-pathologist and laboratory processing is bundled together. However, Mohs micrographic surgery may be more expensive in European systems because the Mohs technique surgeon, pathologist, and laboratory fees may be billed separately.
自 20 世纪 30 年代莫氏显微外科手术问世以来，该技术已被证明在治疗皮肤肿瘤方面具有实用性。本文介绍了莫氏显微外科手术的技术和各种适应证。我们讨论了莫氏显微外科手术在以下皮肤肿瘤中的应用：基底细胞癌、鳞状细胞癌、原位黑色素瘤、隆突性皮肤纤维肉瘤、默克尔细胞癌、微囊性附件癌、非典型纤维黄色瘤和皮脂腺癌。在美国的医疗保健体系中，莫氏显微外科手术具有成本效益，因为外科医生-病理学家和实验室处理的计费是捆绑在一起的。然而，由于莫氏技术外科医生、病理学家和实验室的费用可能分开计费，因此在欧洲体系中，莫氏显微外科手术可能更昂贵。
